Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma.

Ludwig H, Pecherstorfer M, Leitgeb C, Fritz E.

Stem Cells. 1993 Sep;11(5):348-55. Review.

PMID:
8241947
2.

Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

Ludwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, Samonigg H, Kappeler AW, Fritz E.

Cancer. 1995 Dec 1;76(11):2319-29.

3.

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.

Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jäger G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B.

Blood. 1995 Dec 15;86(12):4446-53.

4.

Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors.

Ludwig H, Fritz E, Leitgeb C, Krainer M, Kührer I, Sagaster P, Umek H.

Ann Oncol. 1993 Feb;4(2):161-7.

PMID:
8448084
5.

Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.

Mittelman M, Zeidman A, Fradin Z, Magazanik A, Lewinski UH, Cohen A.

Acta Haematol. 1997;98(4):204-10.

PMID:
9401498
6.

[Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].

Haber J, Spicka I, Petruzelka L, Kolesková E, Straub J, Jonásová A, Pospísilová B.

Vnitr Lek. 1996 Apr;42(4):262-7. Czech.

PMID:
8693713
7.

Recombinant human erythropoietin and the anemia of multiple myeloma.

Barlogie B, Beck T.

Stem Cells. 1993 Mar;11(2):88-94. Review.

PMID:
8457789
8.

Increase of bone marrow cellularity during erythropoietin treatment in myeloma.

Ludwig H, Chott A, Fritz E, Krainer M.

Stem Cells. 1995 Aug;13 Suppl 2:77-87.

PMID:
8520516
9.

Anemia in multiple myeloma.

Ludwig H, Pohl G, Osterborg A.

Clin Adv Hematol Oncol. 2004 Apr;2(4):233-41. Review.

PMID:
16163188
10.

Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.

Osterborg A, Brandberg Y, Molostova V, Iosava G, Abdulkadyrov K, Hedenus M, Messinger D; Epoetin Beta Hematology Study Group.

J Clin Oncol. 2002 May 15;20(10):2486-94.

PMID:
12011126
11.

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.

Case DC Jr, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR, et al.

J Natl Cancer Inst. 1993 May 19;85(10):801-6.

PMID:
8487324
12.
13.

[The level of erythropoietin in patients with anemia and myeloma multiplex treated with erythropoietin].

Ciepłuch H, Zaucha JM, Lysiak-Szydłowska W, Hellmann A.

Pol Arch Med Wewn. 1995 Aug;94(2):153-8. Polish.

PMID:
8596750
14.

Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.

Holley JL, Nolan TA, Piraino B.

Clin Nephrol. 1992 Mar;37(3):145-7.

PMID:
1563119
15.

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P; European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly.

Eur J Cancer. 2007 Jan;43(2):258-70. Epub 2006 Dec 19. Review.

PMID:
17182241
16.

[Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].

Arenas Gracia M, Abad Gosálvez A, Colomina Avilés J, Pascual Pérez R, Ferriz Moreno P.

An Med Interna. 1995 Apr;12(4):187-8. Review. Spanish.

PMID:
7620064
17.

[Erythropoietin treatment of tumor-associated anemia in patients with multiple myeloma].

Ludwig H, Fritz E, Kotzmann H, Gisslinger H.

Onkologie. 1990 Feb;13(1):46-9. German.

PMID:
2186325
18.

Prediction of response to erythropoietin treatment in chronic anemia of cancer.

Ludwig H, Fritz E, Leitgeb C, Pecherstorfer M, Samonigg H, Schuster J.

Blood. 1994 Aug 15;84(4):1056-63.

Items per page

Supplemental Content

Write to the Help Desk